Close Menu
TheKhaleejPost
    What's Hot
    News

    Revolutionizing Cardiac Care: “Beirut Valves” Marks A New Milestone For AUBMC’s Structural Heart Program

    Business

    SBC Summit Malta: Payments Innovation Track to Tackle Fraud, Crypto, Open Banking & More

    Culture

    Tradition Meets Innovation: KRASOTA Dubai’s Iconic Show Menus Embrace the Spirit of Iftar

    Important Pages:
    • Home
    • Privacy Policy
    • Terms & Conditions
    Facebook X (Twitter) Instagram Pinterest
    Facebook X (Twitter) Instagram Pinterest
    TheKhaleejPost
    • Home
    • Technology

      Nokia, CST, ACES NH, along with Mobily and Zain launch industry-first 4.0 GHz spectrum sharing deployment using Neutral Host model in Saudi Arabia

      LG launches “Radio Optimism” campaign to spread “Life’s Good” through music

      EMR June 2025: 5G and FWA accelerating Gulf region’s digital ambitions

      TOD extends its exclusive English Premier League streaming rights in MENA until 2028

      Airalo Partners launches new solution to help businesses slash global roaming costs

    • Business

      Abu Dhabi Quality and Conformity Council organises a strategic retreat to review a comprehensive plan for service excellence

      Charles Group, Patel Family Office sign $1bln real estate pact at Global Wealth Conference

      ChemOne secures landmark $350mln Islamic insurance cover from ICIEC for Pengerang Energy Complex

      Nokia, CST, ACES NH, along with Mobily and Zain launch industry-first 4.0 GHz spectrum sharing deployment using Neutral Host model in Saudi Arabia

      KPMG in Qatar welcomes ICAI Leadership

    • Submit A Press Release
    TheKhaleejPost
    Home » GlobalPharma captures 1.8% market share, marking unprecedented growth in Saudi Arabia
    Business

    GlobalPharma captures 1.8% market share, marking unprecedented growth in Saudi Arabia

    Facebook Twitter Pinterest WhatsApp
    Share
    Facebook Twitter Pinterest WhatsApp

    Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, today announced a significant milestone by capturing a 1.8% market share in the competitive Saudi pharmaceutical landscape. As of May 2024, Globalpharma’s sales surged by 139.5% year-over-year, reaching $12.6 million up from $5.2 million in the same period last year.

    This breakthrough is part of Globalpharma’s strategic endeavour to solidify its presence and expand its market share in Saudi Arabia, one of the fastest-growing pharmaceutical markets in the Middle East.

    During the first five months of 2024, the company reported sales totalling $33.2 million, marking a growth rate of 78.6% and securing a 1.8% market share. From June 2023 to May 2024, Globalpharma’s overall sales were a remarkable $70.3 million, demonstrating a growth of 44.7%.

    Mohammed Saeed Al Raqbani, General Manager, Dubai Investments Industries & Masharie and Board Director of Globalpharma, said: “Globalpharma’s remarkable success in the Saudi market is a reflection of the Group’s strategic initiatives and a commitment to healthcare excellence and patient trust. As we capture 1.8% of this dynamic market, our focus remains steadfast on innovative products and sustainable partnerships that foster growth and significantly improve health outcomes across the region. This milestone underscores our dedication to being at the forefront of health care solutions in Saudi Arabia and beyond. Globalpharma’s success can be attributed to a meticulously planned strategy focusing on major hospitals and chain pharmacies, leveraging partnerships such as those with Wasfaty, and maintaining the highest quality standards. New product launches and an impressive pipeline have garnered increased trust among healthcare professionals, contributing significantly to the company’s growth”.

    “Globalpharma offers products that not only appeal to a wide demographic but also exceed customer’s expectations and excel at the regulatory standards in quality. In the Saudi market, the company focuses on adults of both genders, targeting crucial health concerns such as men’s health, anti-infectives, and hypertension to meet diverse healthcare needs while maintaining exceptional standards in product efficacy and safety. Globalpharma has consistently upheld superior product quality while unveiling several innovative products in the last year. Anticipating even more strategic launches, the company is strengthening its market stance by localizing production for select portfolio items, easing market access, and shortening registration timelines in the process”, said Bassem Albarahmeh, General Manager, Globalpharma.

    In its forward-looking strategy, Globalpharma is set to deepen its footprint in the Saudi market, leveraging strategic partnerships and local manufacturing to meet the demands of both tender and private sectors.

    Share. Facebook Twitter Pinterest WhatsApp
    Previous ArticleIAIDL Launches the World’s First AI Maturity Assessment Compliant with ISO
    Next Article FROM DUBAI TO CAIRO, JDPGLOBAL.COM EYES INVESTMENT IN EGYPTIAN STARTUPS

    Related Posts

    Business

    Abu Dhabi Quality and Conformity Council organises a strategic retreat to review a comprehensive plan for service excellence

    Business

    Charles Group, Patel Family Office sign $1bln real estate pact at Global Wealth Conference

    Business

    ChemOne secures landmark $350mln Islamic insurance cover from ICIEC for Pengerang Energy Complex

    Business

    Nokia, CST, ACES NH, along with Mobily and Zain launch industry-first 4.0 GHz spectrum sharing deployment using Neutral Host model in Saudi Arabia

    Business

    KPMG in Qatar welcomes ICAI Leadership

    Business

    Elevate & Ennismore partner to bring $500mln Mondrian beachfront residence to Al Marjan Island

    Business

    NBK prices $800mln in landmark Additional Tier 1 bond issuance

    Business

    Robin launches from Cairo to lead the region’s advanced data science and AI landscape

    Stay In Touch
    • Facebook
    • Twitter
    Top Picks
    Business

    Burjeel Holdings Receives Inaugural “AAA” MSCI Provisional ESG Rating, Outperforming GCC HealthCare Peers

    Burjeel Holdings PLC (“Burjeel” or “the Group”), a leading super-specialty healthcare services provider in MENA listed on…

    Global Critical Communications Leader Hytera Celebrates 10th Anniversary for Subsidiary in UAE

    LMD’s Most Respected Entities 2023 Crowns Unilever Sri Lanka As The No.1 Most Respected FMCG Company 2023

    Arzan VC launches Revenya Capital to back MENA startups

    DRC Systems Gears Up to Empower Africa’s Digital Revolution at GITEX Africa 2024

    Stay ahead with TheKhaleejPost, your premier destination for breaking news, analysis, and in-depth coverage across the Gulf region and beyond. Discover diverse viewpoints, stay informed, and delve into the stories shaping our communities and world.

    Facebook X (Twitter)
    Categories
    • Business (363)
      • Career (1)
      • Management (5)
      • Startup (11)
    • Culture (73)
    • Entertainment (30)
      • Celebrity (3)
      • Movies (2)
      • TV Shows (1)
    • News (67)
    • Politics (12)
    • Technology (62)
      • Phones (2)
      • Science (1)
    • Videos (10)
    Our Picks
    Technology

    TOD extends its exclusive English Premier League streaming rights in MENA until 2028

    Business

    CNTXT AI Unveils Munsit: The Most Accurate Arabic Speech Recognition Model

    Business

    Smpl Fund I Invests $250,000 in Qora71, Supporting AI and Tech Entrepreneurs in MENA

    © 2025 TheKhaleejPost.
    • Home
    • About Us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.